The Relationship Between Mitral Annular Calcification, Metabolic Syndrome and Thromboembolic Risk
BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY, cilt.34, sa.5, ss.535-541, 2019 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 34 Sayı: 5
- Basım Tarihi: 2019
- Doi Numarası: 10.21470/1678-9741-2019-0062
- Dergi Adı: BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.535-541
- Anahtar Kelimeler: Atrial Fibrilation, Stroke, Metabolic Syndrome, Coronary Artery Disease, Brain Ischemia, Thromboembolism, Hypertension, ATRIAL-FIBRILLATION, OXIDATIVE STRESS, ATHEROSCLEROSIS, PROGRESSION, MANAGEMENT, COMMUNITY, HEART
- Süleyman Demirel Üniversitesi Adresli: Evet
Özet
Introduction: Metabolic syndrome (MetS) is defined as an association between diabetes, hypertension, obesity and dyslipidemia and an increased risk of cardiovascular disease. Mitral annular calcification (MAC) is associated with several cardiovascular disorders, including coronary artery disease, atrial fibrillation (AF), heart failure, ischemic stroke and increased mortality. The CHA(2)DS(2)-VASc score is used to estimate thromboembolic risk in AF. However, the association among MAC, MetS and thromboembolic risk is unknown and was evaluated in the current study.